Nasdaq
$11.99▼ 0.04%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $154.0MShares out 12.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 9.2After-hours26.09.03 05:024Ownership#●●●
MediWound Ltd.
Shmuel Rubinstein, an executive at MediWound Ltd., has filed a Power of Attorney to facilitate compliance with SEC reporting requirements. Under this authorization, Yaron Meyer, the company's General Counsel, is appointed to prepare and file SEC Forms 3, 4, and 5 on his behalf.…more
$11.99-0.04%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.28After-hours26.08.29 05:024Ownership
MediWound Ltd.
Shmuel Hess, an officer of MediWound Ltd., has granted a power of attorney to Yaron Meyer to fulfill SEC reporting obligations. This authorization empowers the attorney-in-fact to prepare and file Forms 3, 4, and 5 with the SEC on behalf of the officer.…more
$11.99-0.04%vs prev closeView filingShare - 8.28Pre-market26.08.28 19:36144Ownership
MediWound Ltd.
Insider Hess Shmuel of MediWound Ltd. has filed SEC Form 144 to report a proposed sale of company securities. This filing formalizes the insider's plan to dispose of their shares.…more
$11.99-0.04%vs prev closeView filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.22Pre-market26.09.22 20:00#●●●#●●●
MediWound Secures Additional $3.3 Million from U.S. Department of War
MediWound has been awarded an additional $3.3 million in non-dilutive funding from the U.S. Department of War to develop a room-temperature-stable version of NexoBrid. This supplemental award brings the total program budget to $21.8 million, supporting the company's progress toward an IND submission.…more
$11.99-0.04%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.14Pre-market26.09.14 20:06
●●●●●●●● ●●●●● ●●●●●●
The DSMB recommended that MediWound's Phase III VALUE study for EscharEx continue without modifications. No safety concerns were identified during the review process.…more
$11.99-0.04%vs prev closeShareBenzinga - 9.2Pre-market26.09.02 20:00
●●●●●●●● ●●●●● ●●●●●●
MediWound announced that its CEO will participate in a fireside chat at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. This event participation is a standard corporate communication and does not provide immediate material impact on the stock price.…more
$11.99-0.04%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report